Shanghai MicroPort Endovascular MedTech Group Co Ltd. Stock Analysis 688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, production, and sale of aortic and peripheral vascular interventional medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 822 full-time employees. The company went IPO on 2019-07-22. The firm's products are mainly categorized into aortic stents, peripheral vascular devices and others. The aortic stent products include thoracic aortic stent graft systems, abdominal aortic stent graft systems, and other surgical accessories. The peripheral vascular and other products mainly include intraoperative stent systems, peripheral arteries, peripheral veins, interventional oncology devices, and peripheral vascular surgical accessories. The firm conducts its businesses in domestic and overseas markets.